Renovaro (RENB) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

RENB Renovaro

Watchlist

1.250
+0.210+20.19%

Close Dec 4 16:00 ET

1.160
-0.090-7.22%

Post 17:12 ET

198.40MMarket Cap-1275P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Renovaro | 10-Q: Q1 2025 Earnings Report
SECNov 14 16:44 ET · Announcements
Renovaro Biosciences Appoints Simon Tarsh as Interim CFO
TipRanksNov 8 16:59 ET
Renovaro BioSciences Issues Shareholder Letter
TipRanksNov 4 08:41 ET
Express News | Renovaro Issues Shareholder Letter and Provides Corporate Update
ReutersNov 4 08:31 ET
Express News | Renovaro Inc Files for Mixed Shelf Offering of up to $200 Mln- SEC Filing
ReutersOct 30 16:31 ET
Renovaro | 10-K/A: Annual report (Amendment)
SECOct 28 17:14 ET · Announcements

Comments

This_Guy

Yesterday 00:54

$Renovaro (RENB.US)$
keeping my eyes on this one

Jaguar8

Oct 17 08:20

NEWS

$Renovaro (RENB.US)$
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
RenovaroCube (NASDAQ: RENB), a leader in AI-driven cancer diagnostics, presented groundbreaking research at the Molecular Analysis for Precision Oncology Congress on October 16, 2024. The study explores the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) from blood plasma to detect copy number alterations (CNAs) in lung cancer patients.
Key findi...